Kieran Pemberton, PhD, is the Senior Director of Research Development for the Children’s Mercy Research Institute where he acts as a liaison between the researchers at Children’s Mercy, the Research Institute leadership team, and the Research Administration team.
Prior to joining Children’s Mercy Kansas City, Dr. Pemberton was the Administrative Director of Frontiers: The Heartland Institute for Clinical and Translational Research, the NIH-funded Clinical and Translational Science Award (CTSA) at the University of Kansas Medical Center (KUMC).
Dr. Pemberton is an experienced scientific, academic and health care administrator. He served as interim director of the Regulatory Knowledge and Support Program of Frontiers and worked with the KUMC Institutional Review Board (IRB) Office on an umbrella IRB reciprocity agreement with Children’s Mercy Kansas City and other Frontiers partner institutes.
Dr. Pemberton represented KUMC on the Kansas City Area Life Sciences Institute’s (KCALSI) Institutional Advisory Committee and Translational Research Experts panel at the Translational Medicine meeting at the University of Missouri in Columbia, Mo., in 2013 and at Kansas State University in Manhattan, Kan., in 2014.
He was a member of the KUMC team that successfully applied for funding of a Clinical Data Research Network award from the Patient-Centered Outcomes Research Institute (PCORI). Children’s Mercy Kansas City is one of the 11 medical institutions that are funded on this award.
Dr. Pemberton is a member of the Scientific Advisory Board of Kansas Patients and Providers Engaged in Prevention Research (KPPEPR) and a committee member of Kansas City University’s IACUC.
Originally from Derry, Northern Ireland, he graduated with a bachelor of science degree in cell biology and immunology from the University College of Wales, Aberystwyth, in 1987. He obtained his PhD in molecular biology from the Medical Research Council’s Clinical Sciences Centre, at Imperial College London, in 1997.
Dr. Pemberton completed postdoctoral training at the National Institute for Medical Research (NIMR) in Mill Hill, London from 1997 – 2000. He joined the Stowers Institute for Medical Research in Kansas City in 2000, where he held a variety of positions including research specialist, senior laboratory manager and chair of the Institutional Animal Care and Use Committee (IACUC). His research focus was on the MLL (Mixed Lineage Leukemia) gene and the role it plays in regulating members of the Hox family of genes.
Dr. Pemberton brings a background in basic science and a thorough understanding of the research grant processes to his position at the Children’s Mercy Research Institute where he will facilitate translational science, bringing the breakthrough results of laboratory research to the hospital’s patients and clinics.